21 träffar

DrugNon-selective α-adrenergic blocker
Phentolamine

…hour. A niche drug: catecholamine-induced hypertensive crisis — phaeochromocytoma, cocaine and amphetamine intoxication, MAO inhibitor crisis — and local treatment of skin necrosis after noradrenaline extravasation.

DrugSGLT2 inhibitor
Empagliflozin

…20 in EMPA-KIDNEY. The glucose-lowering effect diminishes as eGFR falls, but the cardiorenal effect persists — which is the entire point of the drug.

Drugα- and β-agonist
Adrenaline

Adrenalin Stragen EpiPen Jext α- and β-agonist The only drug that reverses all components of anaphylaxis, and the cornerstone of cardiac arrest treatment. The…

DrugLong-acting dihydropyridine calcium channel blocker
Amlodipine

…A cornerstone drug for hypertension and stable angina, and the easiest calcium channel blocker to use: once-daily dosing, a half-life of almost two…

DrugSelective If-channel inhibitor in the sinus node
Ivabradine

…only drug that reduces heart rate without affecting contractility, blood pressure, or conduction — it inhibits the funny current (If) that drives spontaneous depolarisation of the…

DrugXanthine oxidase inhibitor
Allopurinol

…gout, with the goal of titrating upward until serum urate is stably below 360 μmol/l — not setting a fixed dose and leaving it…

DrugMuscarinic receptor antagonist (vagolytic)
Atropine

…nothing happens, which is the entire explanation for why the drug is ineffective in infranodal block. The effect comes within one minute and fades over…

DrugDirect thrombin inhibitor (factor IIa)
Dabigatran

…in patients who may need emergency surgery. The price is that approximately 80 % of absorbed drug is eliminated renally, so renal function governs treatment entirely…

DrugClass IC antiarrhythmic
Flecainide

…in structurally normal hearts. The CAST trial showed increased mortality after myocardial infarction — that boundary remains the most important fact in the drug's history.

DrugHigh-potency first-generation antipsychotic (butyrophenone)
Haloperidol

…The drug has two entirely different dosing worlds: a few milligrams in acute psychotic agitation in younger patients, and tenths of a milligram in delirium…

DrugDirect-acting arteriolar vasodilator
Hydralazine

…making the drug unsuitable as first-line treatment in hypertensive crisis — but useful in pre-eclampsia and as afterload relief in combination with a nitrate…

DrugNon-selective COX inhibitor, propionic acid derivative
Ibuprofen

…quickly, which is an advantage: the drug suits as-needed use and can be discontinued with rapid recovery of renal function and platelet function. The…

DrugNon-selective β₁- and β₂-agonist without alpha effect
Isoprenaline

…while systemic vascular resistance and diastolic blood pressure fall, so the drug raises rate but not pressure. Used where rate itself is the problem: bradycardia…

DrugTricyclic antidepressant
Amitriptyline

…sodium-channel-mediated modulation, not on antidepressant action. What limits treatment is anticholinergic side effects, and what makes the drug dangerous is cardiotoxicity in overdose.

DrugInhaled corticosteroid in fixed combination with long-acting β₂-agonist
Budesonide/formoterol

…maintenance-and-reliever therapy in the same inhaler. The two regimens must never be confused — this is the most common prescribing error with this drug.

DrugLow molecular weight heparin
Dalteparin

…heparin, dalteparin is eliminated renally, so at eGFR below 30 ml/min the effect accumulates and the dose must be adjusted or the drug changed.

DrugSGLT2 inhibitor
Dapagliflozin

…with albuminuria, with or without diabetes. The dose is the same — 10 mg once daily — for all indications, making this drug unusually straightforward to manage.

DrugSynthetic vasopressin analogue (V2 agonist)
Desmopressin

…the V2 receptor means it lacks the vasoconstrictive effect of vasopressin. The danger is not the drug itself but the fluid the patient drinks with…

DrugSelective cholesterol absorption inhibitor
Ezetimibe

…placebo. IMPROVE-IT showed that the additional LDL lowering also translates into fewer cardiovascular events, making ezetimibe the first non-statin drug with outcome data.

DrugPancreatic hormone, glycogenolytic agent and inotrope
Glucagon

GlucaGen HypoKit Glucagon Novo Nordisk Baqsimi Ogluo Pancreatic hormone, glycogenolytic agent and inotrope Two entirely different drugs in the same ampoule. In severe hypoglycaemia, 1…

DrugNMDA-receptor antagonist, dissociative anaesthetic
Ketamine

…never a guarantee. The key practical distinction is between the three dose levels: analgesia, procedural sedation, and induction are different drugs in the same ampoule.